Boston Scientific Appoints Joseph M. Fitzgerald As EVP And COO, Effective January 1, 2027
Fitzgerald currently serves as executive vice president and group president, Cardiovascular, Boston Scientific. Under his leadership, the company has strengthened its portfolio through organic innovation, strategic
Boston Scientific is promoting an experienced leader to chief operating officer. When a company moves a successful executive up, it often signals confidence in their ideas and direction.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.